Coloplast A/S Statistics

Share Statistics

Coloplast A/S has 2.25B shares outstanding. The number of shares has increased by 2.06% in one year.

Shares Outstanding	2.25B
Shares Change (YoY)	2.06%
Shares Change (QoQ)	0.25%
Owned by Institutions (%)	n/a
Shares Floating	142.58M
Failed to Deliver (FTD) Shares	405
FTD / Avg. Volume	0.18%

Short Selling Information

The latest short interest is 62.16K, so 0% of the outstanding shares have been sold short.

Short Interest	62.16K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 39.01 and the forward PE ratio is 3.2. Coloplast A/S's PEG ratio is 34.66.

PE Ratio	39.01
Forward PE	3.2
PS Ratio	7.29
Forward PS	0.5
PB Ratio	10.98
P/FCF Ratio	123.18
PEG Ratio	34.66

Financial Ratio History

Enterprise Valuation

Coloplast A/S has an Enterprise Value (EV) of 41.55B.

EV / Sales	1.54
EV / EBITDA	4.9
EV / EBIT	15.02
EV / FCF	25.97

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.

Current Ratio	1.02
Quick Ratio	0.66
Debt / Equity	1.26
Debt / EBITDA	2.67
Debt / FCF	14.14
Interest Coverage	8.3

Financial Efficiency

Return on Equity is 28.16% and Return on Invested Capital is 13.38%.

Return on Equity	28.16%
Return on Assets	10.51%
Return on Invested Capital	13.38%
Revenue Per Employee	$1.61M
Profits Per Employee	$301.77K
Employee Count	16,741
Asset Turnover	0.56
Inventory Turnover	2.39

Taxes

Income Tax	1.34B
Effective Tax Rate	21%

Stock Price Statistics

The stock price has increased by -21.5% in the last 52 weeks. The beta is 0.55, so Coloplast A/S's price volatility has been higher than the market average.

Beta	0.55
52-Week Price Change	-21.5%
50-Day Moving Average	10.14
200-Day Moving Average	11.64
Relative Strength Index (RSI)	40.75
Average Volume (20 Days)	224,323

Income Statement

In the last 12 months, Coloplast A/S had revenue of 27.03B and earned 5.05B in profits. Earnings per share was 2.25.

Revenue	27.03B
Gross Profit	18.27B
Operating Income	7.32B
Net Income	5.05B
EBITDA	8.48B
EBIT	7.19B
Earnings Per Share (EPS)	2.25

Full Income Statement

Balance Sheet

The company has 788M in cash and 22.63B in debt, giving a net cash position of -21.84B.

Cash & Cash Equivalents	788M
Total Debt	22.63B
Net Cash	-21.84B
Retained Earnings	15.39B
Total Assets	49.15B
Working Capital	-500M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.77B and capital expenditures -1.17B, giving a free cash flow of 1.6B.

Operating Cash Flow	2.77B
Capital Expenditures	-1.17B
Free Cash Flow	1.6B
FCF Per Share	7.11

Full Cash Flow Statement

Margins

Gross margin is 67.59%, with operating and profit margins of 27.08% and 18.69%.

Gross Margin	67.59%
Operating Margin	27.08%
Pretax Margin	23.66%
Profit Margin	18.69%
EBITDA Margin	31.37%
EBIT Margin	27.08%
FCF Margin	5.92%

Dividends & Yields

CLPBY pays an annual dividend of $0.39, which amounts to a dividend yield of 3.32%.

Dividend Per Share	$0.39
Dividend Yield	3.32%
Dividend Growth (YoY)	4.47%
Payout Ratio	126.04%
Earnings Yield	2.56%
FCF Yield	8.12%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for CLPBY.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$11.25
Lynch Upside	18.05%
Graham Number	200.8
Graham Upside	2007.03%

Scores

Altman Z-Score	1.92
Piotroski F-Score	6

Coloplast A/S (CLPBY)